BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 29029302)

  • 21. L-kynurenine treatment alters contextual fear conditioning and context discrimination but not cue-specific fear conditioning.
    Chess AC; Landers AM; Bucci DJ
    Behav Brain Res; 2009 Aug; 201(2):325-31. PubMed ID: 19428652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exposure to elevated embryonic kynurenine in rats: Sex-dependent learning and memory impairments in adult offspring.
    Buck SA; Baratta AM; Pocivavsek A
    Neurobiol Learn Mem; 2020 Oct; 174():107282. PubMed ID: 32738461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tryptophan challenge in individuals with schizophrenia and healthy controls: acute effects on circulating kynurenine and kynurenic acid, cognition and cerebral blood flow.
    Hare SM; Adhikari BM; Mo C; Chen S; Wijtenburg SA; Seneviratne C; Kane-Gerard S; Sathyasaikumar KV; Notarangelo FM; Schwarcz R; Kelly DL; Rowland LM; Buchanan RW
    Neuropsychopharmacology; 2023 Oct; 48(11):1594-1601. PubMed ID: 37118058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral administration of a specific kynurenic acid synthesis (KAT II) inhibitor attenuates evoked glutamate release in rat prefrontal cortex.
    Bortz DM; Wu HQ; Schwarcz R; Bruno JP
    Neuropharmacology; 2017 Jul; 121():69-78. PubMed ID: 28419874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The astrocyte-derived alpha7 nicotinic receptor antagonist kynurenic acid controls extracellular glutamate levels in the prefrontal cortex.
    Wu HQ; Pereira EF; Bruno JP; Pellicciari R; Albuquerque EX; Schwarcz R
    J Mol Neurosci; 2010 Jan; 40(1-2):204-10. PubMed ID: 19690987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation by kynurenine of extracellular kynurenate and glutamate in cerebral cortex of rats with acute liver failure.
    Hilgier W; Kocki T; Obara-Michlewska M; Turski WA; Oja SS; Saransaari P; Albrecht J
    Pharmacol Rep; 2014 Jun; 66(3):466-70. PubMed ID: 24905525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alteration of kynurenic acid concentration in rat plasma following optically pure kynurenine administration: a comparative study between enantiomers.
    Fukushima T; Sone Y; Mitsuhashi S; Tomiya M; Toyo'oka T
    Chirality; 2009 Apr; 21(4):468-72. PubMed ID: 18655158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduction of brain kynurenic acid improves cognitive function.
    Kozak R; Campbell BM; Strick CA; Horner W; Hoffmann WE; Kiss T; Chapin DS; McGinnis D; Abbott AL; Roberts BM; Fonseca K; Guanowsky V; Young DA; Seymour PA; Dounay A; Hajos M; Williams GV; Castner SA
    J Neurosci; 2014 Aug; 34(32):10592-602. PubMed ID: 25100593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective effect of L-kynurenine and probenecid on 6-hydroxydopamine-induced striatal toxicity in rats: implications of modulating kynurenate as a protective strategy.
    Silva-Adaya D; Pérez-De La Cruz V; Villeda-Hernández J; Carrillo-Mora P; González-Herrera IG; García E; Colín-Barenque L; Pedraza-Chaverrí J; Santamaría A
    Neurotoxicol Teratol; 2011; 33(2):303-12. PubMed ID: 20933078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kynurenic acid and 3-hydroxykynurenine production from D-kynurenine in mice.
    Wang XD; Notarangelo FM; Wang JZ; Schwarcz R
    Brain Res; 2012 May; 1455():1-9. PubMed ID: 22498176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dual effect of DL-homocysteine and S-adenosylhomocysteine on brain synthesis of the glutamate receptor antagonist, kynurenic acid.
    Luchowska E; Luchowski P; Paczek R; Ziembowicz A; Kocki T; Turski WA; Wielosz M; Lazarewicz J; Urbanska EM
    J Neurosci Res; 2005 Feb; 79(3):375-82. PubMed ID: 15605380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lesion of the pedunculopontine tegmental nucleus in rat augments cortical activation and disturbs sleep/wake state transitions structure.
    Petrovic J; Ciric J; Lazic K; Kalauzi A; Saponjic J
    Exp Neurol; 2013 Sep; 247():562-71. PubMed ID: 23481548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological Modulation of Sleep Homeostasis in Rat: Novel Effects of an mGluR2/3 Antagonist.
    Hanley N; Paulissen J; Eastwood BJ; Gilmour G; Loomis S; Wafford KA; McCarthy A
    Sleep; 2019 Sep; 42(9):. PubMed ID: 31106825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated levels of kynurenic acid during gestation produce neurochemical, morphological, and cognitive deficits in adulthood: implications for schizophrenia.
    Pershing ML; Bortz DM; Pocivavsek A; Fredericks PJ; Jørgensen CV; Vunck SA; Leuner B; Schwarcz R; Bruno JP
    Neuropharmacology; 2015 Mar; 90():33-41. PubMed ID: 25446576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Astrocyte-derived kynurenic acid modulates basal and evoked cortical acetylcholine release.
    Zmarowski A; Wu HQ; Brooks JM; Potter MC; Pellicciari R; Schwarcz R; Bruno JP
    Eur J Neurosci; 2009 Feb; 29(3):529-38. PubMed ID: 19187269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term exposure to nicotine markedly reduces kynurenic acid in rat brain--in vitro and ex vivo evidence.
    Zielińska E; Kuc D; Zgrajka W; Turski WA; Dekundy A
    Toxicol Appl Pharmacol; 2009 Oct; 240(2):174-9. PubMed ID: 19616570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kynurenic acid leads, dopamine follows: a new case of volume transmission in the brain?
    Wu HQ; Rassoulpour A; Schwarcz R
    J Neural Transm (Vienna); 2007 Jan; 114(1):33-41. PubMed ID: 16932989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated levels of kynurenic acid change the dopaminergic response to amphetamine: implications for schizophrenia.
    Olsson SK; Andersson AS; Linderholm KR; Holtze M; Nilsson-Todd LK; Schwieler L; Olsson E; Larsson K; Engberg G; Erhardt S
    Int J Neuropsychopharmacol; 2009 May; 12(4):501-12. PubMed ID: 18796185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nicotinylalanine increases the formation of kynurenic acid in the brain and antagonizes convulsions.
    Russi P; Alesiani M; Lombardi G; Davolio P; Pellicciari R; Moroni F
    J Neurochem; 1992 Dec; 59(6):2076-80. PubMed ID: 1431895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High tryptophan diet reduces extracellular dopamine release via kynurenic acid production in rat striatum.
    Okuno A; Fukuwatari T; Shibata K
    J Neurochem; 2011 Sep; 118(5):796-805. PubMed ID: 21711351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.